Literature DB >> 28426341

Mydriatics release from solid and semi-solid ophthalmic formulations using different in vitro methods.

Silvia Pescina1, Claudio Macaluso2, Gloria Antonia Gioia1, Cristina Padula1, Patrizia Santi1, Sara Nicoli1.   

Abstract

The aim of the present paper was the development of semi-solid (hydrogels) and solid (film) ophthalmic formulations for the controlled release of two mydriatics: phenylephrine and tropicamide. The formulations - based on polyvinylalcohol and hyaluronic acid - were characterized, and release studies were performed with three different in vitro set-ups, i.e. Franz-type diffusion cell, vial method and inclined plane; for comparison, a solution and a commercial insert, both clinically used to induce mydriasis, were evaluated. Both gels and film allowed for a controlled release of drugs, appearing a useful alternative for mydriatics administration. However, the release kinetic was significantly influenced by the method used, highlighting the need for optimization and standardization of in vitro models for the evaluation of drug release from ophthalmic dosage forms.

Entities:  

Keywords:  Mydriasert®; Mydriatic; diffusion cell; film; gel; in vitro release; inclined plane; ocular drug delivery; vial method

Mesh:

Substances:

Year:  2017        PMID: 28426341     DOI: 10.1080/03639045.2017.1318910

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  2 in total

1.  Adverse Cardiovascular Effects of Phenylephrine Eye Drops Combined With Intravenous Atropine.

Authors:  Qingyu Li; Jianxin Pang; Yang Deng; Shaochong Zhang; Yong Wang; Yang Gao; Xiaoyong Yuan; Yantao Wei; Hongbin Zhang; Junlian Tan; Wei Chi; Wenjun Guo
Journal:  Front Pharmacol       Date:  2021-01-27       Impact factor: 5.810

2.  Ex Vivo Conjunctival Retention and Transconjunctival Transport of Poorly Soluble Drugs Using Polymeric Micelles.

Authors:  Silvia Pescina; Leticia Grolli Lucca; Paolo Govoni; Cristina Padula; Elena Del Favero; Laura Cantù; Patrizia Santi; Sara Nicoli
Journal:  Pharmaceutics       Date:  2019-09-14       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.